Russell Investments Group, Ltd. Ginkgo Bioworks Holdings, Inc. Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$0.28 - $1.16 $14,101 - $58,418	50,361 Added 157.57%	82,322 $27,000
Q1 2024 May 08, 2024	BUY	$1.06 - $1.67 $33,523 - $52,815	31,626 Added 9440.6%	31,961 $37,000
Q4 2023 Feb 05, 2024	BUY	$1.26 - $1.79 $202 - $288	161 Added 92.53%	335 $0
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $667,966 - $1.05 Million	-414,886 Reduced 99.96%	174 $0
Q2 2023 Aug 10, 2023	SELL	$1.14 - $1.95 $745,155 - $1.27 Million	-653,645 Reduced 61.16%	415,060 $772,000
Q1 2023 May 09, 2023	BUY	$1.2 - $2.19 $1.25 Million - $2.27 Million	1,038,052 Added 3386.46%	1,068,705 $1.42 Million
Q3 2022 Nov 04, 2022	BUY	$0.73 - $3.74 $7,874 - $40,343	10,787 Added 54.3%	30,653 $95,000
Q2 2022 Jul 29, 2022	BUY	$2.2 - $4.2 $43,705 - $83,437	19,866 New	19,866 $47,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.